No strategy to meet the HCV epidemic

Por Dalgard, Olav, Mauss, Stefan
Publicado em 2014

Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice

Por Niederau, Claus, Hüppe, Dietrich, Zehnter, Elmar, Möller, Bernd, Heyne, Renate, Christensen, Stefan, Pfaff, Rainer, Theilmeier, Arno, Alshuth, Ulrich, Mauss, Stefan
Publicado em 2012

Reply to Fierer et al

Por Vogel, Martin, Page, Emma, Boesecke, Christoph, Payer, Berit Anna, Schwarze-Zander, Carolynne, Mauss, Stefan, Baumgarten, Axel, Wasmuth, Jan-Christian, Nelson, Mark, Rockstroh, Jürgen K.
Publicado em 2012

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Por Roeder, Claudia, Jordan, Sabine, Schulze zur Wiesch, Julian, Pfeiffer-Vornkahl, Heike, Hueppe, Dietrich, Mauss, Stefan, Zehnter, Elmar, Stoll, Sabine, Alshuth, Ulrich, Lohse, Ansgar W, Lueth, Stefan
Publicado em 2014

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

Por Hofmann, Wolf Peter, Mauss, Stefan, Lutz, Thomas, Schober, Andreas, Böker, Klaus, Moog, Gero, Baumgarten, Axel, Pfeiffer-Vornkahl, Heike, Alshuth, Ulrich, Hüppe, Dietrich, Wedemeyer, Heiner, Manns, Michael P., Schott, Eckart
Publicado no PLoS One (2015)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

Por Niederau, Claus, Mauss, Stefan, Schober, Andreas, Stoehr, Albrecht, Zimmermann, Tim, Waizmann, Michael, Moog, Gero, Pape, Stefan, Weber, Bernd, Isernhagen, Konrad, Sandow, Petra, Bokemeyer, Bernd, Alshuth, Ulrich, Steffens, Hermann, Hüppe, Dietrich
Publicado em 2014

SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients

Por Dieterich, Douglas, Asselah, Tarik, Guyader, Dominique, Berg, Thomas, Schuchmann, Marcus, Mauss, Stefan, Ratziu, Vlad, Ferenci, Peter, Larrey, Dominique, Maieron, Andreas, Stern, Jerry O., Ozan, Melek, Datsenko, Yakov, Böcher, Wulf Otto, Steinmann, Gerhard
Publicado em 2014

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors – Results from the PAN Study

Por Stahmeyer, Jona T., Rossol, Siegbert, Bert, Florian, Böker, Klaus H. W., Bruch, Harald-Robert, Eisenbach, Christoph, Link, Ralph, John, Christine, Mauss, Stefan, Heyne, Renate, Schott, Eckart, Pfeiffer-Vornkahl, Heike, Hüppe, Dietrich, Krauth, Christian
Publicado no PLoS One (2016)

Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS

Por Liptrott, Neill J., Pushpakom, Sudeep, Wyen, Christoph, Fätkenheuer, Gerd, Hoffmann, Christian, Mauss, Stefan, Knechten, Heribert, Brockmeyer, Norbert H., Hopper-Borge, Elizabeth, Siccardi, Marco, Back, David J., Khoo, Saye H., Pirmohamed, Munir, Owen, Andrew
Publicado em 2012

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

Por Dietz, Julia, Rupp, Daniel, Susser, Simone, Vermehren, Johannes, Peiffer, Kai-Henrik, Filmann, Natalie, Bon, Dimitra, Kuntzen, Thomas, Mauss, Stefan, Grammatikos, Georgios, Perner, Dany, Berkowski, Caterina, Herrmann, Eva, Zeuzem, Stefan, Bartenschlager, Ralf, Sarrazin, Christoph
Publicado no PLoS One (2016)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis

Por Price, Huw, Dunn, David, Pillay, Deenan, Bani-Sadr, Firouze, de Vries-Sluijs, Theodora, Jain, Mamta K., Kuzushita, Noriyoshi, Mauss, Stefan, Núñez, Marina, Nüesch, Reto, Peters, Marion, Reiberger, Thomas, Stephan, Christoph, Tan, Lionel, Gilson, Richard
Publicado em 2013

Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection

Por Jaroszewicz, Jerzy, Reiberger, Thomas, Meyer-Olson, Dirk, Mauss, Stefan, Vogel, Martin, Ingiliz, Patrick, Payer, Berit Anna, Stoll, Matthias, Manns, Michael P., Schmidt, Reinhold E., Flisiak, Robert, Wedemeyer, Heiner, Peck-Radosavljevic, Markus, Rockstroh, Jürgen, Cornberg, Markus
Publicado em 2012

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3(+) T Regulatory Cells Correlates with Progressive Disease

Por Schulze zur Wiesch, Julian, Thomssen, Adriana, Hartjen, Philip, Tóth, Ilona, Lehmann, Clara, Meyer-Olson, Dirk, Colberg, Kristina, Frerk, Sebastian, Babikir, Dalia, Schmiedel, Stefan, Degen, Olaf, Mauss, Stefan, Rockstroh, Jürgen, Staszewski, Schlomo, Khaykin, Pavel, Strasak, Alexander, Lohse, Ansgar W., Fätkenheuer, Gerd, Hauber, Joachim, van Lunzen, Jan
Publicado em 2011

Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C

Por Nattermann, Jacob, Vogel, Martin, Nischalke, Hans Dieter, Danta, Mark, Mauss, Stefan, Stellbrink, Hans-Jörg, Baumgarten, Axel, Mayr, Christoph, Bruno, Raffaele, Tural, Cristina, Klausen, Gerd, Clotet, Bonaventura, Naumann, Uwe, Lutz, Thomas, Rausch, Michael, Schewe, Knud, Bienek, Bernhard, Haerter, Georg, Sauerbruch, Tilman, Rockstroh, Juergen K., Spengler, Ulrich
Publicado em 2011

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

Por Wyen, Christoph, Hendra, Heidy, Vogel, Martin, Hoffmann, Christian, Knechten, Heribert, Brockmeyer, Norbert H., Bogner, Johannes R., Rockstroh, Jürgen, Esser, Stefan, Jaeger, Hans, Harrer, Thomas, Mauss, Stefan, van Lunzen, Jan, Skoetz, Nicole, Jetter, Alexander, Groneuer, Christiane, Fätkenheuer, Gerd, Khoo, Saye H., Egan, Deirdre, Back, David J., Owen, Andrew
Publicado em 2008

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

Por Neukam, Karin, Munteanu, Daniela I., Rivero-Juárez, Antonio, Lutz, Thomas, Fehr, Jan, Mandorfer, Mattias, Bhagani, Sanjay, López-Cortés, Luis F., Haberl, Annette, Stoeckle, Marcel, Márquez, Manuel, Scholten, Stefan, de los Santos-Gil, Ignacio, Mauss, Stefan, Rivero, Antonio, Collado, Antonio, Delgado, Marcial, Rockstroh, Juergen K., Pineda, Juan A.
Publicado no PLoS One (2015)

Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

Por Rotger, Margalida, Glass, Tracy R., Junier, Thomas, Lundgren, Jens, Neaton, James D., Poloni, Estella S., van 't Wout, Angélique B., Lubomirov, Rubin, Colombo, Sara, Martinez, Raquel, Rauch, Andri, Günthard, Huldrych F., Neuhaus, Jacqueline, Wentworth, Deborah, van Manen, Danielle, Gras, Luuk A., Schuitemaker, Hanneke, Albini, Laura, Torti, Carlo, Jacobson, Lisa P., Li, Xiuhong, Kingsley, Lawrence A., Carli, Federica, Guaraldi, Giovanni, Ford, Emily S., Sereti, Irini, Hadigan, Colleen, Martinez, Esteban, Arnedo, Mireia, Egaña-Gorroño, Lander, Gatell, Jose M., Law, Matthew, Bendall, Courtney, Petoumenos, Kathy, Rockstroh, Jürgen, Wasmuth, Jan-Christian, Kabamba, Kabeya, Delforge, Marc, De Wit, Stephane, Berger, Florian, Mauss, Stefan, de Paz Sierra, Mariana, Losso, Marcelo, Belloso, Waldo H., Leyes, Maria, Campins, Antoni, Mondi, Annalisa, De Luca, Andrea, Bernardino, Ignacio, Barriuso-Iglesias, Mónica, Torrecilla-Rodriguez, Ana, Gonzalez-Garcia, Juan, Arribas, José R., Fanti, Iuri, Gel, Silvia, Puig, Jordi, Negredo, Eugenia, Gutierrez, Mar, Domingo, Pere, Fischer, Julia, Fätkenheuer, Gerd, Alonso-Villaverde, Carlos, Macken, Alan, Woo, James, McGinty, Tara, Mallon, Patrick, Mangili, Alexandra, Skinner, Sally, Wanke, Christine A., Reiss, Peter, Weber, Rainer, Bucher, Heiner C., Fellay, Jacques, Telenti, Amalio, Tarr, Philip E.
Publicado em 2013